Natixis Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $647K | Buy |
52,887
+33,163
| +168% | +$406K | ﹤0.01% | 1421 |
|
|
2025
Q1 | $283K | Sell |
19,724
-6,220
| -24% | -$89.2K | ﹤0.01% | 1558 |
|
|
2024
Q4 | $413K | Buy |
25,944
+4,492
| +21% | +$71.5K | ﹤0.01% | 1509 |
|
|
2024
Q3 | $515K | Buy |
21,452
+2,574
| +14% | +$61.8K | ﹤0.01% | 1448 |
|
|
2024
Q2 | $376K | Buy |
18,878
+3,077
| +19% | +$61.3K | ﹤0.01% | 1484 |
|
|
2024
Q1 | $315K | Buy |
15,801
+1,659
| +12% | +$33.1K | ﹤0.01% | 1470 |
|
|
2023
Q4 | $317K | Buy |
+14,142
| New | +$317K | ﹤0.01% | 1458 |
|
|
2023
Q3 | – | Sell |
-18,217
| Closed | -$466K | – | 1487 |
|
|
2023
Q2 | $466K | Buy |
18,217
+2,877
| +19% | +$73.6K | ﹤0.01% | 1353 |
|
|
2023
Q1 | $456K | Buy |
15,340
+1,721
| +13% | +$51.2K | ﹤0.01% | 1327 |
|
|
2022
Q4 | $369K | Buy |
+13,619
| New | +$369K | ﹤0.01% | 1361 |
|
|
2022
Q2 | – | Sell |
-11,287
| Closed | -$378K | – | 1457 |
|
|
2022
Q1 | $378K | Buy |
+11,287
| New | +$378K | ﹤0.01% | 1333 |
|